Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.

Address

9237 E Via de Ventura Boulevard

Suite 105

Website

https://www.journeymedicalcorp.com

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - Specialty & Generic

Key Executives

Mr. Joseph Benesch

CFO/Controller

Dr. Lindsay A. Rosenwald, M.D.

Chairman of the Board/Director

Mr. Neil Herskowitz

Director

Ms. Miranda Jayne Toledano

Director

Mr. Claude Maraoui

CEO/Director/Founder/President

Mr. Justin Smith

Director

Ownership

Institution Holdings

TANG CAPITAL MANAGEMENT LLC

576,100 (3.113%)

Renaissance Technologies Corp

261,000 (1.410%)

American Financial Group Inc

180,000 (0.973%)

Vanguard Group Inc

129,448 (0.699%)

EAM Investors, LLC

110,509 (0.597%)

Neuberger Berman Group LLC

94,479 (0.510%)

Neuberger Berman Investment Advisers LLC

94,479 (0.510%)

Geode Capital Management, LLC

85,785 (0.463%)

Fidelity Management & Research Company LLC

78,439 (0.424%)

Millennium Management LLC

75,031 (0.405%)

Individual Holdings

Mr. Claude Maraoui

2,153,430 (17.747%)

Dr. Lindsay A. Rosenwald, M.D.

114,245 (0.942%)

Mr. Justin Smith

104,717 (0.838%)

Mr. Neil Herskowitz

71,717 (0.591%)

Ms. Miranda Jayne Toledano

71,717 (0.591%)

Mr. Joseph Benesch

60,710 (0.485%)

Funds Holdings

Fidelity Extended Market Index Fund

40,385 (0.218%)

Details

Overview

Company Info

Key Ratios

Income

Balance Sheet

Cash Flow

Bubble

Make Smart Investment Choices